Mission
The Thomas L. Petty Aspen Lung Conference aims to address the escalating prevalence of emphysema due to various factors, including aging and environmental impacts. The conference serves as an international platform for researchers and clinicians to exchange ideas on lung health, specifically focusing on emphysema and related diseases. It integrates basic, translational, and clinical approaches to enhance understanding and treatment of lung diseases, aiming for effective strategies for early identification and intervention.
Basic Information
Founded in
2002
EIN
84-1606032
Total Assets
$2.659 million
UN Sustainable Development Goals Supported
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
At a Glance
Call for Abstracts
The 67th Annual Conference invites submissions of abstracts on emphysema research.
Upcoming Conference Dates
The 67th Annual Meeting will be held on June 3-6, 2025.
Health and Safety Guidelines
Attendee safety guidelines will comply with CDC and NIH regulations.
Impact Stats
Years Since Established
Established Conference
The Aspen Lung Conference was initially organized to facilitate the exchange of new ideas and research on emphysema.
Papers Published Annually
Publication Output
The conference faculty publishes over 400 scholarly peer-reviewed papers yearly, along with various monographs and editorials.
International Participants
International Collaboration
Brings together leading researchers from various medical fields to foster collaboration and advancements in lung health.
Past Events
2024 Aspen Lung Conference
June 2024
Held a successful Annual Aspen Lung Conference focusing on emphysema research.
Upcoming Events
67th Annual Thomas L. Petty Aspen Lung Conference
June 3-6, 2025
An international forum focusing on advances in emphysema research.
Learn MoreMIP Score (Beta)
The MIP Score is in beta! We'd love any feedback you may have.
The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.
Overall Score
47
30
/100
Program Expense Ratio
42.23%
4
/20
Program Revenue Growth
0.00%
2
/20
Leverage Ratio
0
2
/20
Working Capital Ratio
10.09
20
/20
Fundraising Efficiency
0
2
/20
Latest Filing Data: Form 990
Fiscal Year:2023
Source:Source: Self-reported by organization
Financial Details
Revenue
| Category | Amount | Percentage |
|---|---|---|
| Contributions, Gifts, and Grants | 142.5K | 51.40% |
| Program Services | 0 | 0.00% |
| Investment Income | 60.74K | 21.91% |
| Sales of Non-Inventory Assets | 74K | 26.69% |
| Other Notable Sources | 0 | 0.00% |
| Total Revenue | 277.2K | 100.00% |
Related Nonprofits
Foundation for Lung Pathobiology
Med Research
Lung Disease ResearchAmerican Skin Association Inc.
Med Research
Lung Disease ResearchRespire Health Foundation
Med Research
Lung Disease ResearchMla Charitable Foundation Inc.
Med Research
Lung Disease ResearchScleroderma Research Foundation
Med Research
Lung Disease Research